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TECHNICAL NOTES Open Access
3D whole-heart phase sensitive inversion
recovery CMR for simultaneous black-blood
late gadolinium enhancement and
bright-blood coronary CMR angiography
Giulia Ginami1* , Radhouene Neji1,2, Imran Rashid1, Amedeo Chiribiri1, Tevfik F. Ismail1, René M. Botnar1,3
and Claudia Prieto1,3
Abstract
Background: Phase sensitive inversion recovery (PSIR) applied to late gadolinium enhancement (LGE) imaging is
widely used in clinical practice. However, conventional 2D PSIR LGE sequences provide sub-optimal contrast
between scar tissue and blood pool, rendering the detection of subendocardial infarcts and scar segmentation
challenging. Furthermore, the acquisition of a low flip angle reference image doubles the acquisition time without
providing any additional diagnostic information. The purpose of this study was to develop and test a novel 3D
whole-heart PSIR-like framework, named BOOST, enabling simultaneous black-blood LGE assessment and bright-blood
visualization of cardiac anatomy.
Methods: The proposed approach alternates the acquisition of a 3D volume preceded by a T2-prepared Inversion
Recovery (T2Prep-IR) module (magnitude image) with the acquisition of a T2-prepared 3D volume (reference image).
The two volumes (T2Prep-IR BOOST and bright-blood T2Prep BOOST) are combined in a PSIR-like reconstruction to
obtain a complementary 3D black-blood volume for LGE assessment (PSIR BOOST). The black-blood PSIR BOOST and
the bright-blood T2Prep BOOST datasets were compared to conventional clinical sequences for scar detection and
coronary CMR angiography (CMRA) in 18 patients with a spectrum of cardiovascular disease (CVD).
Results: Datasets from 12 patients were quantitatively analysed. The black-blood PSIR BOOST dataset provided
statistically improved contrast to noise ratio (CNR) between blood and scar when compared to a clinical 2D PSIR
sequence (15.8 ± 3.3 and 4.1 ± 5.6, respectively). Overall agreement in LGE depiction was found between 3D
black-blood PSIR BOOST and clinical 2D PSIR acquisitions, with 11/12 PSIR BOOST datasets considered diagnostic.
The bright-blood T2Prep BOOST dataset provided high quality depiction of the proximal coronary segments, with
improvement of visual score when compared to a clinical CMRA sequence. Acquisition time of BOOST (~10 min),
providing information on both LGE uptake and heart anatomy, was comparable to that of a clinical single CMRA sequence.
Conclusions: The feasibility of BOOST for simultaneous black-blood LGE assessment and bright-blood coronary
angiography was successfully tested in patients with cardiovascular disease. The framework enables free-breathing
multi-contrast whole-heart acquisitions with 100% scan efficiency and predictable scan time. Complementary
information on 3D LGE and heart anatomy are obtained reducing examination time.
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Background
Late gadolinium enhancement (LGE) cardiovascular mag-
netic resonance (CMR) imaging has become the gold
standard for the assessment of myocardial viability in dif-
ferent cardiac pathologies, including myocardial infarction
[1, 2] and myocarditis [3–5]. In addition, LGE imaging
provides pre-interventional assessment of arrhythmogenic
substrate in patients undergoing electrophysiology pro-
cedures as well as visualization of lesions after ablation
[6–8], and is gaining importance in the characterization
of fibrosis in non-ischemic cardiomyopathies [9–12].
LGE imaging is typically performed 10–20 min after
the administration of a gadolinium (Gd)-based contrast
agent using T1-weighted inversion recovery (IR) se-
quences [1, 13–15]. The inversion time (TI) is normally
set to null the signal from the healthy myocardium, thus
enhancing the contrast to noise ratio (CNR) between
viable and diseased myocardial tissue. IR sequences,
however, are prone to reduced scar to blood and scar
to remote myocardium contrast when a sub-optimal TI
is selected. Phase-sensitive IR (PSIR) LGE acquisitions
have been introduced to provide intrinsic robustness
with respect to the TI selection [16]. Conventional PSIR
sequences are based on the acquisition of an IR-prepared
image (referred to as “magnitude image”), interleaved with
a proton density image (referred to as “reference image”)
that is acquired at a low flip-angle, which are then com-
bined as described in [16]. Although PSIR normally
achieves excellent contrast between viable myocardium
and scar tissue, the contrast between blood pool and LGE
uptake is often suboptimal. This leads to difficulties in de-
lineating sub-endocardial infarcts that are adjacent to the
blood pool. Furthermore, unclear borders between scar
tissue and blood affect the accuracy of scar segmentation
that is crucial for infarct size and transmurality measure-
ments as well as for the planning of electrophysiology pro-
cedures [17, 18]. Black-blood PSIR LGE has been
introduced [19] to improve the contrast between the
blood pool and scar tissue by exploiting an inversion pulse
in combination with a T2 preparation (T2Prep) module
(T2Prep-IR) [19–21]. However, a limitation of all PSIR
frameworks is that the acquisition efficiency is intrinsically
sub-optimal as the low flip-angle reference image has lim-
ited diagnostic value. Furthermore, most of the LGE PSIR
implementations are limited to 2D acquisitions that are
performed during a breath-hold to minimize respiratory
motion artefacts. Recently, free-breathing whole-heart
PSIR acquisitions have been introduced [22, 23] and inte-
grated with diaphragmatic navigator gating [24]. The use
of diaphragmatic navigator gating, however, leads to re-
duced scan efficiency and unpredictable acquisition times
that can make the selection of the correct TI challenging.
In addition, residual imaging artefacts may be observed as
a result of the combination of the inversion pulse with the
diaphragmatic navigator [25]. In order to overcome these
drawbacks, we propose the extension of a 3D whole-heart
Bright-blood and black-blOOd phase SensiTive inversion
recovery (BOOST) sequence [26] – that has been recently
introduced for non-contrast enhanced visualization of
coronary lumen and thrombus – to black-blood LGE
imaging. The proposed post-contrast BOOST sequence
exploits a T2Prep-IR module for the acquisition of the
magnitude image, enabling black-blood LGE PSIR recon-
struction. Furthermore, the acquisition of the reference
image is designed to provide a complementary and fully
co-registered bright-blood dataset for the visualization of
the heart anatomy, the great vessels, and the coronary
lumen. The entire framework has been integrated with
image-based navigation [27] to achieve 100% scan effi-
ciency and predictable scan time. In this study, the
feasibility of BOOST for post-contrast simultaneous
black-blood LGE imaging and bright-blood heart anat-
omy, great vessels, and coronary lumen visualization
was tested in a cohort of cardiovascular patients at the
end of a clinical CMR examination.
Methods
Framework implementation
An electrocardiogram -triggered free-breathing 3D
whole-heart balanced steady-state free precession (bSSFP)
prototype sequence was implemented as described in [26]
and as illustrated in Fig. 1. The sequence alternates the ac-
quisition of a T2-prepared IR volume in odd heartbeats
(T2Prep-IR BOOST, magnitude image) and a T2-prepared
volume in even heartbeats (bright-blood T2Prep BOOST,
reference image). Both acquisitions are performed with a
Cartesian trajectory with spiral profile order [28] and with
a high flip-angle of 90 degrees. A 2D low-resolution
image-based navigator (iNAV) [27] is acquired at each
heartbeat to estimate translational respiratory motion
along the superior-inferior (SI) and right-left (RL) direc-
tions and to enable beat-to-beat motion correction with
100% scan efficiency and predictable scan time. Prior to
data acquisition, a rectangular region of interest (ROI) is
selected covering the whole heart along the RL direction
and covering the base and the mid part of the heart along
the SI direction. RL and SI translational motion is then es-
timated using a template-matching algorithm [29] and
motion compensation is performed by modulating the k-
space data with a linear shift before image reconstruction
[27]. Motion estimation is performed for the T2Prep-IR
BOOST and T2Prep BOOST datasets independently. For
each dataset, respiratory motion correction is performed
at the end-expiratory level [30].
The motion corrected T2Prep-IR BOOST and T2Prep
BOOST volumes are then rigidly co-registered and com-
bined in a PSIR-like reconstruction as described in [16]
to obtain a complimentary PSIR BOOST black-blood
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volume. The PSIR-like reconstruction is performed using
the T2Prep BOOST dataset as reference image. As the
T2Prep BOOST is designed for coronary lumen
visualization, it exhibits high tissue contrast. Thus,
voxel-by-voxel intensity normalization of the resulting
PSIR BOOST volume by the reference image is not
performed in order to preserve adequate contrast in
the resulting black-blood LGE volume.
All acquisitions reported in this study were performed
on a 1.5 T CMR system (Magnetom Aera, Siemens
Healthineers, Erlangen, Germany) using an 18-channel
chest-coil and a 32-channel spine coil. The study was
approved by the National Research Ethics Service (15/
NS/0030) and written informed consent was obtained
from each participant according to institutional guide-
lines. Motion estimation and correction, image recon-
struction, and PSIR-like computation were implemented
using the scanner software (Syngo MR E11A, Siemens
Healthineers).
Sequence simulations
The longitudinal magnetization behavior of healthy
viable myocardium, scar and blood was investigated
via simulations for the proposed post-contrast
BOOST sequence. This was compared against the
corresponding simulations for previously published
LGE PSIR and bright-blood coronary angiography
post-contrast sequences. Sequence simulations were
performed in Matlab R2016a (The MathWorks, Inc.,
Natick, Massachusetts, USA).
Three different CMR sequences were simulated using
the extended phase graphs (EPG) formalism [31]: 1) the
BOOST sequence as illustrated in Fig. 1; 2) a conven-
tional PSIR sequence for LGE assessment as described
in [16]; 3) a dedicated T2-prepared bright-blood se-
quence for coronary CMRA [32]. The simulated tissue
parameters were set as follows: healthy viable myocardium
T1 = 550 ms, T2 = 45 ms; scar T1 = 300 ms, T2 = 45 ms;
and post-contrast blood T1 = 450 ms, T2 = 200 ms. The T1
and T2 values of the tissues of interest were set to match
those of the standardized phantom [33] used in this study,
as described in the following paragraphs, and to approxi-
mate the properties of tissues about 15 min after gadolin-
ium contrast injection [33, 34]. Accordingly, imaging
parameters were set to match those of the performed
phantom acquisitions. For both the BOOST and the con-
ventional PSIR sequences, the TI was set to null the signal
from healthy viable myocardium at odd heartbeats (corre-
sponding to TI = 150 ms for the BOOST sequence and to
TI = 350 ms for the conventional PSIR sequence). T2Prep
duration was set to 40 ms for odd and even heartbeats of
the BOOST sequence, and for the CMRA sequence. A
flip-angle of 90 degrees was simulated for both the acqui-
sition of the magnitude and the bright-blood reference
Fig. 1 Proposed post-contrast BOOST framework for simultaneous 3D whole-heart bright-blood coronary angiography and black-blood late
gadolinium enhancement (LGE) assessment. A T2-prepared inversion recovery (T2Prep-IR) module is applied at odd heartbeats (T2Prep-IR
BOOST, magnitude image) (a), whereas data acquisition is T2 prepared and performed with a high flip angle at even heartbeats (bright-blood
T2Prep-BOOST, reference image) (b). A 3D Cartesian trajectory with spiral profile order [28] is used for data acquisition; data collection is segmented over
multiple heartbeats (yellow, red, blue) to minimize the effects of cardiac motion. Even heartbeat acquisitions include a SPIR pulse for fat saturation,
while a STIR-like fat suppression is employed in odd heartbeats. 3D data acquisition at each heartbeat is preceded by a low-resolution 2D image-based
navigator (iNAV) that is used to estimate translational respiratory motion along the superior-inferior and right-left directions. The two motion corrected
datasets (T2Prep-IR BOOST and T2Prep BOOST) are combined in a PSIR-like reconstruction to generate a third, complementary, black-blood dataset
(PSIR BOOST) for LGE visualization (c). The motion corrected bright-blood T2Prep BOOST dataset (reference image, b) provides adequate contrast for
heart anatomy, great vessel, and coronary lumen visualization
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image in the BOOST sequence as well as for the acquisi-
tion of the magnitude image in the conventional PSIR se-
quence. A flip-angle of 8 degrees was simulated for the
reference image of the conventional PSIR sequence. For
the CMRA sequence, a 90 degrees flip angle was simu-
lated for each heartbeat. For all three sequences (BOOST,
conventional PSIR, and CMRA), and for each individual
heartbeat, a data acquisition duration equal to 120 ms was
simulated, corresponding to 33 k-space lines. To minimize
signal oscillations during acquisition, and to generate the
iNAVs at each individual heartbeat, 14 bSSFP linear ramp-
up pulses were simulated prior to imaging data acquisi-
tion. The heart-rate was simulated at 60 beats per minute
with a total of 50 heartbeats (of which 2 were dummy
heartbeats).
For all the simulated sequences, expected magnetization
Mz/M0 as well as absolute signal differences between the
tissues of interest were computed. All the absolute signal
differences (that are preserved in the final PSIR recon-
struction) were computed at the beginning of the data ac-
quisition using centric k-space ordering.
Phantom experiments
Data acquisition
A standardized T1 and T2 phantom, with different vials
resembling T1 and T2 values of the most relevant cardiac
compartments [33], was used for data acquisition.
Healthy myocardium, scar, and post-contrast blood T1
and T2 values were identical to the simulated ones. Data
acquisition was performed using the BOOST sequence,
the conventional PSIR sequence, and the dedicated
CMRA acquisition. T2Prep durations, TIs, heart rate,
number of k-space lines acquired per heartbeat and flip
angle values were kept identical to those used in the
simulations. Additional imaging parameters included:
transverse orientation, Field of view (FOV) =
320x320x60 mm3, in-plane spatial resolution = 1 mm2,
slice thickness = 2 mm, echo-time (TE) / repetition time
(TR) = 1.56/3.6 ms, pixel bandwidth 977 Hz/pixel. The
PSIR BOOST reconstruction was performed with and
without intensity normalization for comparison purposes.
Data analysis
Signal to noise ratio (SNR) and CNR were quantified for
the three sequences (BOOST, conventional PSIR, and
dedicated CMRA). SNR of blood (SNRblood), healthy vi-
able myocardium (SNRmyo) and scar (SNRscar) were cal-
culated for the odd heartbeats of BOOST and
conventional PSIR, together with CNR between blood
and healthy myocardium (CNRblood-myo), scar and blood
(CNRscar-blood), and scar and healthy viable myocardium
(CNRscar-myo). SNRblood and CNRblood-myo were quantified
for even heartbeats for both the BOOST and the conven-
tional PSIR sequence as well as for the dedicated CMRA
acquisition. For the PSIR images obtained from the
BOOST sequence (with and without intensity
normalization) and the conventional PSIR sequence,
CNRblood-myo, CNRscar-blood, and CNRscar-myo were
quantified after the removal of low spatial frequency
signal components as described in [16, 35].
In-vivo experiments
Data acquisition
Eighteen patients (52.7 ± 13.2 years, 9 males) who were
referred for a clinical CMR examination were recruited
for this study. In 16 out of 18 (89%) patients, a conven-
tional 2D multi-slice and multi breath-hold bSSFP Car-
tesian PSIR sequence [16] was acquired in different
orientations (four chamber view, three chamber view,
short-axis view) starting 10 min after gadobutrol
(0.2 mmol/kg) administration (Gadovist, Bayer, Berlin,
Germany). Relevant imaging parameters for this acquisi-
tion include: FOV = 292 × 152 mm2, slice thickness =
8 mm, in plane spatial resolution = 1.4 mm2, 10 slices ac-
quired for the short axis view, TE/TR = 1.26/2.9 ms, pixel
bandwidth = 775 Hz/pixel, flip angle = 45 degrees, ECG
triggering to the most quiescent diastolic period. The TI
(typically ranging from 200 ms – 300 ms) was selected with
a dedicated TI scout scan and was set to null the signal
from the healthy viable myocardium. In 7 out of 18 (39%)
subjects, a conventional free-breathing navigator-gated
bright-blood whole-heart T2-prepared bSSFP (CMRA)
Cartesian sequence was acquired after the breath-hold
2D PSIR sequences. For this acquisition, imaging param-
eters were set as follows: sagittal orientation, subject-
specific FOV = 410x307x160–192 mm3, in plane spatial
resolution = 1.4 mm2, slice thickness = 1.4 mm, TE/TR =
1.56/3.6 ms, pixel bandwidth = 575 Hz/pixel, flip angle =
90 degrees, T2Prep duration = 40 ms, 2× GRAPPA parallel
imaging acceleration [36] with 24 calibration lines. Re-
spiratory motion was compensated using diaphragmatic
navigator gating and tracking (tracking factor equal to
0.6 [37]), with an acceptance window placed in end-
expiration and with an amplitude equal to ±3.5 mm.
At the end of the clinical examination, the proposed
ECG-triggered BOOST sequence was acquired under
free-breathing and using the following imaging parameters:
coronal orientation, in-plane spatial resolution = 1 mm2,
slice thickness = 4 mm (interpolated to 2 mm during image
reconstruction), subject-specific FOV = 320x320x80–
130 mm3, TE/TR = 1.56/3.6 ms, pixel bandwidth 977 Hz/
pixel. For both the magnitude image T2Prep-IR BOOST
and the reference image T2Prep BOOST, the flip angle
was set to 90 degrees and the T2Prep duration was equal
to 40 ms. The subject-specific TI (typically ranging in the
interval 100–180 ms) was selected to null the signal from
viable healthy myocardium by acquiring a dedicated 2D
BOOST TI scout scan during a breath-hold; such scout
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scan consisted of a magnetization-prepared cine sequence
where a T2Prep-IR module is applied right after the R-
wave at odd heartbeats, whereas T2-preparation solely is
performed at the beginning of the cardiac cycle in even
heartbeats. Cine frames belonging to the odd heartbeats
were visually inspected to determine the optimized TI. In
odd heartbeats, fat signal was suppressed for the effect of
the inversion pulse (STIR-like approach) [38], while spec-
tral pre-saturation (SPIR) [39] was used to suppress signal
from epicardial fat at even heartbeats (Fig. 1). Images ob-
tained in patients for whom BOOST data acquisition did
not start later than 40 min after contrast injection were
considered for further quantitative and qualitative data
analyses. This temporal restriction was set to avoid a too
pronounced washout of the contrast agent.
Quantitative data analysis
Quantitative data analysis was performed for the images
acquired with the clinical 2D PSIR sequence, and for the
3D black-blood LGE and bright-blood CMRA datasets
obtained with BOOST (PSIR BOOST and T2Prep
BOOST, respectively). ROIs were manually drawn in
blood, healthy viable myocardium and scar tissue (when
present) at matching anatomical locations for both the
clinical 2D PSIR and the 3D whole-heart PSIR BOOST
images. Background noise was computed from a ROI
with uniform signal positioned at the level of the liver,
following the removal of low spatial frequency signal
components as performed for the phantom images
[16, 35]. CNRblood-myo, CNRscar-blood and CNRscar-myo
were quantified for both the clinical 2D PSIR and the
3D whole-heart PSIR BOOST images. CNR values
were quantified in the subjects for whom both the 2D
PSIR and BOOST sequences were acquired, and com-
pared using a paired 2-tailed Student t-test. P = 0.05
was set as the threshold to determine statistical signifi-
cance. Acquisition times of all the acquired sequences
(2D PSIR acquisition – including pauses between
breath-holds –, clinical whole-heart CMRA, and BOOST)
were recorded. In addition, scan efficiency was recorded
for the clinical CMRA acquisition with diaphragmatic
navigator gating.
Qualitative data analysis
All the datasets (3D black-blood PSIR BOOST, 3D
bright-blood T2Prep BOOST, conventional 3D CMRA
acquisition, and clinical 2D PSIR) were anonymized and
stored in a randomized order. Qualitative grading of the
anonymized images was performed by two experienced
cardiologists (T.F.I. and I.R., SCMR III certification)
blinded to clinical data. For all the LGE images (black-
blood 3D PSIR BOOST and 2D clinical PSIR), presence
and location of LGE were assessed. Furthermore, images
were graded in terms of diagnostic quality on consensus
basis using a 4-point scale system where 1 indicates a
fully diagnostic dataset without the presence of artefacts,
2 indicates a diagnostic dataset with only minor artefacts
present, 3 indicates a diagnostic dataset with significant
artefacts, and 4 indicates an artefacts-rendering images
non-diagnostic dataset. Subjective scores for LGE
visualization were compared with a paired Wilcoxon
signed-rank test to assess statistical differences; P < 0.05
was considered statistically significant. Statistical ana-
lyses were performed considering the cases for whom
both the clinical 2D PSIR and the BOOST sequences
were acquired. For all acquired bright-blood datasets
(conventional 3D CMRA and T2Prep BOOST), the abil-
ity to identify the origin and the proximal course of the
coronary arteries was graded for four relevant coronary
segments: left main (LM), left anterior descending cor-
onary artery (LAD), left circumflex coronary artery
(LCX), and right coronary artery (RCA). Grading was
performed on consensus basis using a 4-point scale sys-
tem as that used for the grading of LGE datasets.
Results
All data acquisitions and reconstructions were carried
out successfully and all quantified endpoints are re-
ported hereafter.
Sequence simulations
All simulated pulse sequences (proposed post-contrast
BOOST sequence, conventional PSIR sequence [16], and
dedicated post-contrast CMRA acquisition [32]) and the
resulting steady state magnetization behavior for blood,
myocardium and scar tissues are reported in Fig. 2. For
the T2Prep-IR BOOST sequence (odd heartbeats) the ex-
pected magnetization Mz/M0 of the healthy viable myo-
cardium, blood and scar varied within the intervals
0.000–0.059, −0.158 – 0.003, and 0.108–0.116, respect-
ively, during imaging data acquisition. This resulted in
an absolute signal difference between myocardium and
scar of +0.108 and of +0.266 between blood and scar.
For the conventional PSIR sequence, and in correspond-
ence to the acquisition of the magnitude image, the ex-
pected magnetization Mz/M0 of the healthy viable
myocardium varied within the interval − 0.002 – 0.058,
whereas the expected magnetization Mz/M0 of blood
and scar varied within the intervals 0.056–0.146 and
0.207–0.144, respectively. This resulted in an absolute
signal difference between healthy myocardium and scar
amounting to +0.208, and of +0.151 between blood and
scar. For the conventional PSIR sequence, the reference
image at even heartbeats (low flip-angle) exhibited high
values of expected magnetization Mz/M0, varying in the
intervals 0.807–0.858, 0.877–0.919 and 0.951–0.967, for
healthy viable myocardium, blood, and scar tissue, re-
spectively. Conversely, even heartbeats of the BOOST
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sequence (T2Prep BOOST) exhibited reduced expected
magnetization Mz/M0 for the tissues of interest, since
data acquisition is performed with higher flip-angle and
is preceded by a T2Prep. Specifically, the expected
magnetization Mz/M0 of healthy viable myocardium,
blood and scar varied within the intervals 0.230–0.123,
0.490–0.420 and 0.267–0.167, respectively. This resulted
in a blood/myocardium ratio of 2.13, which is adequate
for anatomy and coronary lumen visualization. Similarly,
for the conventional post-contrast CMRA sequence, the
expected magnetization Mz/M0 of healthy viable myo-
cardium, blood and scar varied within the intervals
0.220–0.100, 0.498–0.438, and 0.267–0.161, respectively,
leading to a blood/myocardium ratio equal to 2.26.
Phantom experiments
Phantom images obtained with the proposed post-contrast
BOOST sequence, the conventional PSIR sequence [16],
and the dedicated post-contrast CMRA acquisition are
shown in Fig. 2. ROIs corresponding to post-contrast blood,
healthy viable myocardium, and scar are indicated by red,
blue and yellow circles, respectively. All the endpoints that
were quantified for the phantom acquisitions are summa-
rized in the Additional file 1. The T2Prep-IR BOOST phan-
tom dataset showed strong signal from both blood and scar
tissue, while providing suppression of the signal belonging
to the vial mimicking the viable myocardium. The magni-
tude image of the conventional PSIR acquisition showed ef-
fective suppression of signal from the viable myocardium,
and high signal from the vial mimicking the scar. The refer-
ence image T2Prep BOOST, designed for the visualization
of the heart anatomy, great vessels, and coronary lumen,
showed SNRblood and CNRblood-myo comparable to those
provided by the dedicated CMRA acquisition. Conversely,
the reference image of the conventional PSIR acquisition
(acquired at a low flip angle) showed reduced SNRblood and
CNRblood-myo. The PSIR reconstructions obtained using the
BOOST sequence with and without normalization are dis-
played in Fig. 3. Reduced tissue contrast is observed for the
PSIR reconstruction with intensity normalization. Con-
versely, tissue contrast was restored in the PSIR reconstruc-
tion without intensity normalization. The PSIR BOOST
phantom dataset (obtained without intensity normalization)
showed effective blood signal suppression, leading to im-
proved CNRscar-blood when compared to the more conven-
tional PSIR sequence.
In-vivo experiments
Quantitative and qualitative data analysis was performed
for 12 of 18 patients for whom BOOST data acquisition
started less than 40 min after contrast agent injection.
The average time after injection for the BOOST datasets
Fig. 2 Sequence simulations and phantom images comparing BOOST and conventional sequences for LGE assessment and CMRA. Simulated
magnetization of the post-contrast BOOST sequence (a, b), of a conventional PSIR sequence (f, g), and of a dedicated post-contrast CMRA
sequence (k, l) are displayed. The expected longitudinal magnetization (Mz/M0) is reported for blood (red lines), healthy viable myocardium
(blue lines), and scar tissue (orange lines). Furthermore, results from the phantom experiments are displayed (BOOST: c, d, e; PSIR: h, i, j;
CMRA: m) and the vial of interest are highlighted (blood – red circle, healthy viable myocardium – blue circle, and scar tissue – orange circle).
Comparable contrast between the scar tissue and healthy viable myocardium can be observed in the PSIR reconstructions obtained with the BOOST
sequence (PSIR BOOST) and the conventional PSIR sequence. Differently, improved contrast between the scar tissue and the healthy viable
myocardium can be observed in the PSIR BOOST dataset when compared to the conventional PSIR sequence (phantom images in e and j).
Data acquired with BOOST at even heartbeats (T2Prep BOOST, d) exhibit higher signal when compared to the reference image of the conventional
PSIR sequence, acquired at a low flip-angle (i). In particular, T2Prep BOOST shows comparable signal and tissue contrast to that of a dedicated
T2 prepared CMRA sequence (m)
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was 27:47 ± 3:35 min. Among those patients, the acquisi-
tion of the clinical 2D PSIR sequence and of the clinical
3D whole-heart CMRA with diaphragmatic navigator
was performed in 10 and 6 cases, respectively. Clinical,
imaging, and demographic characteristics are summarized
in Table 1. Acquisition times were 7:48 ± 4:03 min for the
clinical 2D PSIR sequence (including pauses between
breath-holds), 13:06 ± 3:05 min for the conventional
CMRA acquisition with diaphragmatic navigator (with an
average scan efficiency of ~ 47%), and 12:07 ± 1:56 min for
data acquisition with BOOST that provides both black-
blood LGE and bright-blood anatomical images. For the
BOOST sequence, image-based navigation enabled data
acquisition with 100% scan efficiency (i.e., none of the ac-
quired data was discarded during image reconstruction)
and predictable scan time. Furthermore, translational mo-
tion correction led to effective respiratory motion correc-
tion for both the bright-blood T2Prep and the black-blood
PSIR BOOST datasets in most cases, as shown in Fig. 4
for two representative patients.
Quantitative data analysis
The endpoints quantified for the conventional 2D PSIR
sequence amounted to CNRblood-myo = 15.2 ± 8.1,
CNRblood-scar = 4.1 ± 5.6 and CNRscar-myo = 12.3 ± 9.3.
The black-blood PSIR BOOST datasets presented effect-
ive nulling of the blood signal, leading to significantly
improved CNRblood-scar (equal to 15.8 ± 3.3, P < 0.025) and
significantly reduced CNRblood-myo (4.2 ± 3.6, P < 0.001)
when compared to the clinical 2D PSIR sequence (Fig. 5).
Quantified CNRscar-myo was equal to 13.02 ± 4.56 (P =NS
in comparison to the clinical 2D PSIR sequence).
Qualitative data analysis
Eleven of 12 3D PSIR BOOST datasets were considered
diagnostic, with an average grade of 1.75 ± 1.21; specific-
ally, 8/12 cases were graded 1, one single case was
graded 2, two cases – where incomplete blood suppres-
sion was observed – were graded 3, and one single case
was graded 4 due to the presence of residual motion and
pronounced artefacts originating from the rigid transla-
tion of the chest wall and arms. Complete correspond-
ence between clinical 2D PSIR acquisitions and 3D PSIR
BOOST datasets was found in 8/10 cases in terms of
LGE findings and location of the LGE uptake. In two in-
dividual cases (Patient 08 and Patient 10) LGE was not
visible in the 3D PSIR BOOST dataset. Both datasets
were graded 1, meaning no residual artefacts were visible
and optimal blood signal suppression was achieved. In
these two cases, however, BOOST data acquisition
started 39:57 min and 39:32 min after contrast injection,
following a conventional 3D CMRA acquisition (dur-
ation 17:04 min and 11:31 min) that was performed be-
tween the 2D clinical PSIR and the 3D BOOST
sequences. This particularly pronounced delay between
the two LGE acquisitions, together with the absence of
residual artefacts and the achievement of adequate blood
signal suppression in the PSIR BOOST datasets, suggests
that contrast agent washout prevented adequate scar de-
piction. Clinical 2D PSIR images were graded 1 for all
the 10 patients where the sequence was acquired. No
Fig. 3 Phantom images obtained with the BOOST and the conventional PSIR sequence. Imaging data were acquired by nulling the signal from
the healthy viable myocardium (blue vial) in the magnitude images (a, e). Differently from f, the T2Prep BOOST dataset, acquired at a high flip-
angle, exhibits both high signal from the blood (red vial) and pronounced contrast between blood and healthy viable myocardium (b). The PSIR
reconstruction obtained with BOOST and using intensity normalization (d) shows reduced tissue contrast, which is restored once intensity
normalization is not applied (c). Furthermore, such restored contrast between the scar tissue (orange vial) and the healthy viable myocardium is
comparable to that of the PSIR reconstruction in (g), while improved contrast between scar and blood can be appreciated
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statistically significant difference was found in terms of
visual grading (P = NS) when comparing the 3D PSIR
BOOST datasets and the clinical 2D PSIR counterpart
(average grade of BOOST in these 10 patients: 1.80 ±
1.31). In terms of coronary conspicuity, image quality
scores evaluated by consensus grading were 1.50 ± 1.22
(LM), 2.00 ± 1.54 (LAD), 2.50 ± 1.64 (LCX) and 2.83 ± 1.16
(RCA) for the conventional CMRA with diaphragmatic
navigator (6 patients, Table 1). A trend of improvement in
terms of coronary delineation was quantified with BOOST
in the same 6 patients; for those subjects, LM and LAD
were graded 1 in all cases. For LCX and RCA, average
grades were equal to 1.50 ± 1.22 and 1.50 ± 0.83, respect-
ively. A visual comparison between T2Prep BOOST data-
sets and conventional CMRA is shown in Fig. 6. Overall
visual grading obtained with T2Prep BOOST (considering
the entire cohort of 12 patients, which includes cases
where the acquisition of the conventional CMRA was
not performed) was 1.07 ± 0.27 for the LM, 1.07 ± 0.27
for the LAD, 1.07 ± 0.27 for the LCX, and 1.53 ± 0.77
for the RCA.
Fusion of a bright-blood T2Prep BOOST with a black-
blood PSIR BOOST datasets (obtained with the Horos
software, V1.1.7) is illustrated in Fig. 7 to demonstrate
the location and transmurality of the infarct obtained
from the black-blood PSIR dataset.
Discussion
In this study, we extended the use of a novel PSIR-like
framework, referred to as BOOST, to post-contrast ap-
plications for simultaneous 1) black-blood LGE assess-
ment and 2) bright-blood heart anatomy, great vessels,
and coronary lumen visualization. With the BOOST
framework, the acquisition of the magnitude image
(T2Prep-IR BOOST) is based on a T2Prep-IR module for
optimal contrast between the blood pool and scar tissue
after PSIR computation (black-blood PSIR BOOST).
Furthermore, the acquisition of the reference image
(bright-blood T2Prep BOOST) is performed with a high
flip-angle and it is preceded by a T2Prep module. This
ensures adequate signal and tissue contrast for the
visualization of heart anatomy, great vessels, and the
coronary lumen. In contrast to previously published ap-
proaches providing a single bright-blood dataset for the
simultaneous visualization of LGE and proximal coron-
ary arteries [40], our framework generates two separate
yet co-registered 3D volumes, each one being specifically
designed and optimized for the visualization of the cor-
onary lumen (bright-blood T2Prep BOOST) and myocar-
dial scar (black-blood PSIR BOOST).
Sequence simulations and phantom acquisitions showed
that the proposed post-contrast PSIR BOOST dataset
achieves improved scar-blood contrast when compared to
Table 1 Summary of patients’ data used for quantitative analysis
Gender Age (years) Heartbeats
per minute
Clinical Condition LGE findings 3D whole heart
CMRA
Patient 01 F 25 85 Atrial fibrillation No Yes
Patient 02 F 30 70 Atrial fibrillation
(previous myocarditis)
No No
Patient 03 F 48 70 Eosinophilic Granulomatous Polyangitis
(Churg-Strauss syndrome)
No No
Patient 04 M 50 80 Myocarditis Yes
Diffuse mid-wall
No
Patient 05 M 67 55 Myocardial infarction Yes
Transmural
No
Patient 06 M 56 65 Advanced Hypertensive
heart disease
No
(no 2D PSIR)
Yes
Patient 07 M 66 70 Myocardial infarction Yes
Transmural and subendocardial
No
Patient 08 M 62 80 Myocardial infarction Yes
Mid-wall
Yes
Patient 09 M 59 45 Myocardial infarction Yes
Subendocardial
Yes
Patient 10 F 30 75 Myocardial infarction Yes
Subendocardial
Yes
Patient 11 F 74 80 Myocardial infarction Yes
Transmural
No
Patient 12 M 52 75 Suspected myocardial infarction No
(no 2D PSIR)
Yes
Furthermore, the presence of LGE findings is stated (“no 2D PSIR” pertains the cases where 2D PSIR acquisition was not performed and presence of LGE uptake
was assessed with BOOST only). In addition, it is indicated whether the acquisition of the conventional, 3D whole-heart CMRA sequence was performed or not
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a more conventional PSIR sequence for LGE imaging [16];
this was confirmed by in vivo measurements in patients.
While the PSIR BOOST volume provided adequate LGE
depiction in most of the patients with positive findings,
phantom experiments indicate higher CNRscar-myo in the
T2Prep-IR BOOST datasets, where precise viable myocar-
dial nulling is achieved; this can be qualitatively appreci-
ated in vivo as shown in Fig. 5. As such, referring to the
T2Prep-IR BOOST dataset for the detection of subtle,
non-ischemic, fibrosis patterns might be preferable; this
aspect, however, needs further investigation and will be
analyzed in future studies. Furthermore, sequence simula-
tions show that the bright-blood T2Prep BOOST dataset
provides SNRblood and CNRblood-myo similar to those of a
dedicated T2-prepared post-contrast CMRA acquisition.
In vivo acquisitions showed that respiratory motion cor-
rected bright-blood T2Prep BOOST datasets allowed
visualization of the origin and the proximal course of the
coronary arteries (LM, LAD, LCX, and RCA) with high
diagnostic quality. A trend of improvement was observed
in comparison to the conventional CMRA; respiratory
motion compensation performed with diaphragmatic navi-
gator gating assumes a fixed linear correlation between
the respiratory motion of the liver and that of the heart.
The fixed correlation factor of 0.6 [37] that was used in
this study might have been inexact for some of the sub-
jects, thus leading to sub-optimal motion compensation.
Conversely, with the use of image-based navigation, re-
spiratory motion information can be directly extracted
from the heart itself, thus avoiding the risk of imprecise
approximations. In addition, with image-based navigation,
it is possible to correct for movements along both SI and
RL directions [27]. These aspects may have been a con-
tributing factor of the improved coronary delineation that
was obtained with BOOST. Furthermore, and as predicted
by sequence simulations, the black-blood PSIR BOOST
Fig. 4 Improvement in BOOST image quality after translational motion correction in two representative patients. The use of translational motion
correction along the SI and RL directions reduces blurring artefacts and improves coronary vessel sharpness in the bright-blood T2Prep BOOST
datasets (arrows in a, c, e, and g). Motion compensation recovers also small details as showed in the zoomed images. Furthermore, improved
image sharpness can be observed on the black-blood PSIR-like reconstructions (arrows in b, d, f, and h), where a sharper delineation of the LGE
uptake can be appreciated following motion correction (f versus h)
Ginami et al. Journal of Cardiovascular Magnetic Resonance  (2017) 19:94 Page 9 of 14
reconstruction provided visualization of LGE with diag-
nostic quality in most cases and significantly improved
CNRscar-blood was quantified in comparison to clinical 2D
PSIR acquisitions [16].
The PSIR reconstruction performed with the proposed
framework exactly follows that described in [16], with
the exception of the intensity normalization step that is
conventionally performed at the end of the PSIR pipe-
line. In contrast to previously published post-contrast
PSIR sequences [16], the reference image (T2Prep
BOOST) acquired in our approach exhibits high tissue
contrast, thus preventing the application of surface coil
intensity normalization. In fact, the presence of high tis-
sue contrast in the reference image significantly alters
the resulting contrast of the normalized PSIR recon-
struction (Fig. 3). The use of surface coil intensity
normalization is typically exploited to compensate for
large variations in the intensity of the image caused by
rapid fall-off of the surface-coil fields, thus improving
the local tissue contrast. This was shown to be particu-
larly beneficial for the visualization of subendocardial
infarcts, given the fact that the contrast between scar tis-
sue and blood is particularly reduced in conventional
PSIR acquisitions [16]. With this new sequence configur-
ation, however, intrinsically enhanced contrast between
blood and scar tissue is provided using a T2Prep-IR
module for the acquisition of the magnitude image; in
addition, the use of pre-scan based normalization readily
available on commercial scanners can be exploited to
compensate for variations in signal intensity. This might
alleviate the need for surface coil intensity normalization,
however further validation may be needed to corroborate
this point.
The integration of the framework with image-based
navigation enabled data acquisition during free-
breathing with 100% scan efficiency and predictable scan
time. The acquisition time for BOOST (approximately
12 min) was similar to that of a conventional CMRA ac-
quisition with diaphragmatic navigator (approximately
13 min), considering an average scan efficiency of 50%
and 2× parallel imaging acceleration. The BOOST
framework, however, provides both a bright- and black-
Fig. 5 Comparison between the proposed 3D whole-heart BOOST framework and the clinical 2D PSIR acquisition. Images in a, e, and i show the
LGE uptake as depicted in the T2Prep-IR BOOST datasets (white arrows), where signal from the blood pool is present and the viable myocardium
is suppressed. Reformats in b, f, and j show the coronary reformats obtained from the 3D whole-heart bright-blood T2Prep BOOST dataset.
Complementary 3D black-blood LGE images obtained with BOOST are shown in c, g, and k. All the images from the T2Prep-IR BOOST and the
PSIR BOOST datasets were reformatted to match the orientation of the clinical 2D PSIR acquisitions (d, h, and l). The LGE uptake identified in
both the T2Prep-IR BOOST and PSIR BOOST datasets matches that of the clinical 2D PSIR acquisition. Furthermore, improved contrast between
the scar tissue and the blood pool can be appreciated in the 3D PSIR BOOST datasets when compared to the 2D PSIR acquisition (g, k versus h, l,
orange arrows). LGE uptake appears more shallow and blood pool signal is not entirely suppressed in Patient 04 with myocarditis (c, d, orange arrows),
due to a longer TI
Ginami et al. Journal of Cardiovascular Magnetic Resonance  (2017) 19:94 Page 10 of 14
blood dataset in the same acquisition time, whereas the
overall acquisition of conventional CMRA and 2D PSIR
sequences was about 20 min in our cohort of patients.
This intrinsic efficiency of the BOOST framework holds
potentials for reducing the scan time that is currently
needed to perform a complete CMR examination. This
might be particularly beneficial in the case of claustro-
phobic, anxious, or clinically unstable patients. Addition-
ally, reducing the overall examination time would imply
economic benefits and reduction of patients waiting lists.
Future technical developments of the BOOST sequence
will include the integration of acceleration techniques
[36, 41, 42] to improve both the nominal acquisition
time as well as the spatial resolution. Furthermore, im-
provements in the acquired spatial resolution might en-
able isotropic acquisitions that would, for instance, allow
for more robust visualization of the mid and distal cor-
onary arteries. Similarly, the achievement of higher
spatial resolution could benefit tissue characterization,
allowing for a more accurate delineation of scar tissue
and enabling a more accurate image fusion between the
bright-blood T2Prep BOOST and the black-blood PSIR
BOOST datasets for the assessment of scar location and
transmurality. Additionally, the framework will be inte-
grated with algorithms for arrhythmia rejection that
could further improve the image quality that was ob-
tained in this study. Currently, BOOST is combined with
image-based navigation enabling in-line translational
motion correction along the SI and RL directions.
However, the breathing pattern in patients is often
more complex and involves translation, rotation, and
non-rigid deformations [43–45]. Therefore, future
technical developments will aim at combining the BOOST
framework with strategies for non-rigid respiratory
motion correction [46] that might be particularly benefi-
cial in very sick patients who often have irregular
Fig. 6 Comparison between conventional 3D whole-heart acquisition with diaphragmatic navigator and the proposed bright-blood T2Prep
BOOST. Improved delineation of the RCA can be appreciated in Patient 01 with T2Prep BOOST when compared to the conventional CMRA
acquisition (arrows in a, b). Dilated aorta can be observed in Patient 06 due to the presence of hypertensive heart disease (d, e). Excellent
coronary delineation was obtained with both sequences in Patient 10 (g, h). Furthermore, the complementary black-blood PSIR BOOST datasets
for LGE assessment are shown in c, f, and i
Ginami et al. Journal of Cardiovascular Magnetic Resonance  (2017) 19:94 Page 11 of 14
breathing patterns [47]. In addition, the use of non-rigid
respiratory motion correction may help to reduce ghost-
ing artefacts that may originate from rigid translation of
static tissues such as the chest wall and arms during the
motion correction process. Similarly, a rigid registration
between the T2Prep-IR BOOST dataset and the T2Prep
BOOST dataset is currently performed prior PSIR
computation to compensate for residual mis-registration
errors; this may be also sub-optimal and the use of non-
rigid registration could further improve the quality of the
resulting PSIR BOOST dataset and additionally reduce the
risk of phase errors that may originate in portions of the
image where phases are not varying smoothly (e.g. in cor-
respondence to the interface between different tissues).
In this study, the BOOST acquisition was performed at
the end of a clinical CMR examination as it was consid-
ered unethical to potentially jeopardize the acquisition
of conventional LGE data at the expense of a novel se-
quence at this stage. Injection timing was optimized to
provide optimal contrast agent concentration during the
acquisition of the clinical 2D PSIR sequences, thus pro-
viding suboptimal contrast conditions for the BOOST
scan. This was noticed particularly in two specific cases
(Patient 08 and Patient 10), where LGE uptake could not
be depicted despite the absence of motion artefacts and
the achievement of optimal blood signal suppression.
Furthermore, as the BOOST acquisition was performed
at the end of the clinical scan, there may have been more
respiratory or heart-rate irregularities that might have
had an additional detrimental effect on the image quality
that was obtained with BOOST. However, scan time was
not prolonged by more than 15 min at most. Therefore,
future studies are warranted to rigorously compare the
proposed post-contrast 3D BOOST sequence and conven-
tional 2D PSIR acquisitions by, for instance, randomizing
the order of the two acquisitions and by performing separ-
ate Gd injections to ensure equivalent contrast conditions.
Kellman et al. [19] demonstrated that black-blood LGE
provides improved conspicuity of subendocardial infarcts;
future studies will aim at investigating the accuracy of
black-blood PSIR BOOST for the quantification of scar
transmurality and, thus, regional viability assessment. Fur-
thermore, accuracy in the detection and quantification of
ischaemic scar will be validated. Similarly, further clinical
validation of BOOST is needed in comparison to conven-
tional CMRA in patients with angiographically confirmed
coronary artery disease.
The improved contrast between blood pool and scar
provided by the proposed black-blood PSIR BOOST im-
ages may facilitate scar segmentation. However, the nul-
ling of the blood and viable myocardium signal reduces
the depiction of the heart anatomy and might challenge
the localization of the scar itself. This challenge can be
addressed by fusing the co-registered black blood PSIR
dataset with the bright blood whole heart dataset,
which then allows both scar and myocardial anatomy
visualization as shown in Fig. 7. This characteristic
makes this framework particularly suitable for the planning
of electrophysiology procedures. Similarly, the framework
may be beneficial for the visualization of lesions after abla-
tion and follow-up of patients. This further enlarges the
spectrum of potential clinical applications of post-contrast
Fig. 7 Fusion of the bright-blood T2Prep BOOST and the black blood PSIR BOOST datasets. Images correspond to two representative patients with
positive LGE findings. Bright-blood images for visualization of the heart anatomy are shown in a, d (T2Prep-BOOST). Complementary visualization
of scar tissue (PSIR BOOST) is shown in b, e; these datasets could potentially be used for an easy scar segmentation, as unclear border
between the surrounding tissues and the scar itself have disappeared. Fusion images, where the anatomical localization of the scar can be
retrieved, are shown in c, f
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BOOST, that will be tested in dedicated studies in the up-
coming future.
Conclusions
We demonstrated the feasibility of simultaneous black-
blood LGE imaging and bright-blood visualization of car-
diac anatomy, the great vessels, and the coronary artery
lumen using a novel motion corrected multi-contrast 3D
imaging sequence, referred to as BOOST. Data acquisition
with BOOST was performed in free-breathing and ensures
whole-heart coverage, 100% scan efficiency, and predict-
able scan time. The framework was validated in a group of
cardiac patients and showed high quality depiction of the
coronary arteries in comparison to standard CMRA and
good agreement with 2D PSIR LGE scar visualization.
This novel sequence has a broad spectrum of potential
clinical applications.
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